Adrenoleukodystrophy Clinical Trials 2022

Browse 8 Adrenoleukodystrophy Medical Studies Across 10 Cities

2 Phase 3 Trial · 16 Adrenoleukodystrophy Clinics

Reviewed by Michael Gill, B. Sc.
8 Adrenoleukodystrophy Clinical Trials Near Me
Worcester, MA
Boston, MA
Palo Alto, CA
Baltimore, MD
More Trial Locations
An interactive map to display trial locations for University of Massachusetts Chan Medical School, Massachusetts General Hospital, Viking Clinical Site 203, Viking Clinical Site 201, and 11 more locations.
Top Hospitals for Adrenoleukodystrophy Clinical Trials
Location
Active Adrenoleukodystrophy Clinical Trials
All Time Trials for Adrenoleukodystrophy
First Recorded Adrenoleukodystrophy Trial
Trials
Massachusetts General Hospital, Boston, Massachusetts
2
3
2017
University of Massachusetts Chan Medical School, Worcester, Massachusetts
1
1
2022
Viking Clinical Site 203, Palo Alto, California
1
1
2021
Viking Clinical Site 201, Baltimore, Maryland
1
1
2021
Viking Clinical Site 207, Gainesville, Florida
1
1
2021
Top Treatments for Adrenoleukodystrophy Clinical Trials
Treatment Name
Active Adrenoleukodystrophy Clinical Trials
All Time Trials for Adrenoleukodystrophy
First Recorded Adrenoleukodystrophy Trial
Trials
SBT101
1
1
2022
Blood and Marrow Transplant
1
1
2018
Top Cities for Adrenoleukodystrophy Clinical Trials
City
Active Adrenoleukodystrophy Clinical Trials
Top Active Site for Adrenoleukodystrophy Clinical Trials
Trial List
Palo Alto, California
2
Viking Clinical Site 203
Baltimore, Maryland
2
Viking Clinical Site 201
Worcester, Massachusetts
1
University of Massachusetts Chan Medical School
Which phases are most popular for adrenoleukodystrophy clinical trials?
How many adrenoleukodystrophy clinical trials are open to youth and / or seniors?
Most Recent Adrenoleukodystrophy Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
6/30/2022
Phase 1 & 2
Phase 3 Adrenoleukodystrophy Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Pediatric Adrenoleukodystrophy Clinical Trials
Senior Friendly Adrenoleukodystrophy Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
6/30/2022
Phase 1 & 2

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 8th, 2021

Last Reviewed: August 20th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.